Back to RYTM
GOLDMAN SACHS GROUP INC → RYTM
GOLDMAN SACHS GROUP INC RYTM Position History
Rhythm Pharmaceuticals, Inc. • Healthcare
Quarters held
20
Latest value
$349K
Q2 2026
Peak value
$181.7M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $101.2M |
| Q2 2025 | $8M |
| Q2 2025 | $365K |
| Q3 2025 | $168.4M |
| Q3 2025 | $22.4M |
| Q3 2025 | $201K |
| Q3 2025 | $201K |
| Q4 2025 | $252K |
| Q4 2025 | $21.3M |
| Q4 2025 | $174.4M |
| Q4 2025 | $174.4M |
| Q4 2025 | $21.3M |
| Q4 2025 | $252K |
| Q1 2026 | $149.9M |
| Q1 2026 | $21.1M |
| Q2 2026 | $181.7M |
| Q2 2026 | $53.5M |
| Q2 2026 | $216K |
| Q2 2026 | $308K |
| Q2 2026 | $349K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $349K | 3.1K | — | — |
| Q2 2026 | $308K | 2.8K | — | — |
| Q2 2026 | $216K | 1.9K | — | — |
| Q2 2026 | $53.5M | 482.3K | — | — |
| Q2 2026 | $181.7M | 1.64M | — | — |
| Q1 2026 | $21.1M | 242.2K | — | — |
| Q1 2026 | $149.9M | 1.72M | — | — |
| Q4 2025 | $252K | 2.4K | — | — |
| Q4 2025 | $21.3M | 198.9K | — | — |
| Q4 2025 | $174.4M | 1.63M | — | — |
| Q4 2025 | $174.4M | 1.63M | — | — |
| Q4 2025 | $21.3M | 198.9K | — | — |
| Q4 2025 | $252K | 2.4K | — | — |
| Q3 2025 | $201K | 2.0K | — | — |
| Q3 2025 | $201K | 2.0K | — | — |
| Q3 2025 | $22.4M | 221.9K | — | — |
| Q3 2025 | $168.4M | 1.67M | — | — |
| Q2 2025 | $365K | 5.8K | — | — |
| Q2 2025 | $8M | 126.5K | — | — |
| Q2 2025 | $101.2M | 1.60M | — | — |
Other funds holding RYTM
$285.7M
$285.7M
$259.7M
$197.6M
$140.3M
$140.3M
$138.9M
$122.1M